Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients
- Conditions
- Pulmonary EmbolismDeep Vein Thrombosis
- Interventions
- Diagnostic Test: Proximal lower limb ultrasound
- Registration Number
- NCT05112705
- Brief Summary
The DETECT randomized controlled trial addresses the question of whether surveillance ultrasound in critically ill patients by facilitating DVT detection reduces the incidence of PE and lowers all-cause 90-day mortality. The primary outcome is 90-day all-cause mortality.
- Detailed Description
This is an open-label multicenter multinational randomized-controlled trial. All patients admitted to ICU will be screened within the first 48 hours of ICU admission for eligibility. Subjects who meet all criteria for enrollment will be randomized via a password-protected, secure website using a variable-size block concealed computer-generated randomization procedure. Patients will be allocated to twice weekly bilateral lower limb ultrasound or standard care (control) in a 1:1 ratio.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1800
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ultrasound Group Proximal lower limb ultrasound Patients will be receiving twice weekly proximal lower limb ultrasound
- Primary Outcome Measures
Name Time Method 90-day mortality 90 days Mortality 90 days post randomization
- Secondary Outcome Measures
Name Time Method Proximal DVT From randomization date to day 28 or ICU discharge whichever comes first Lower limb proximal leg DVT, defined as partially or completely incompressible venous segment.
Pulmonary Embolism From randomization date and throughout hospital stay up to day 28 Pulmonary embolism defined as definite PE (characteristic intraluminal filling defect on CT chest, high probability VQ scan or detected at autopsy); probable PE (moderate-high pretest, no test or a non-diagnostic test); possible PE (low pre-test probability, non-diagnostic test) or No PE (negative or normal test)
Clinically important bleeding From randomization date and throughout hospital stay up to day 90 Fatal bleeding, symptomatic bleeding in critical organ or bleeding causing fall in hemoglobin, requiring transfusion or interventional radiology
Trial Locations
- Locations (1)
King Abdulaziz Medical City
🇸🇦Riyadh, Saudi Arabia